Forrester Research, Inc.
FORR Nasdaq Services-Engineering, Accounting, Research, Management Financials FY2016–FY2025
Last close · Oct 23, 2026
$12.48
0.3%What Forrester Research, Inc. does
No business description yet.
- Legal name
- FORRESTER RESEARCH, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 13, 2026
- Accession · CIK
- 0001193125-26-105114
0001023313
Revenue and margins
Forrester Research, Inc. had $397M of revenue in fiscal 2025, down 8.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $18.1M in fiscal 2025, 4.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Forrester Research, Inc. returned $2.5M to shareholders in fiscal 2025, 14% of free cash flow. The diluted share count fell 0.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Forrester Research, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $116M | $104M | $72.9M | $56.1M | $63.3M |
| Debt incl. finance leases | $75.0M | $50.0M | $35.0M | $35.0M | $35.0M |
| Net debt / EBITDA | −0.8x | −1.3x | −2.5x | −2.5x | — |
| Debt / equity | 0.4x | 0.2x | 0.1x | 0.2x | 0.3x |
| Interest coverage | 9.2x | 13.3x | — | — | — |
| Current ratio | 0.9x | 0.9x | 0.9x | 1.0x | 0.9x |
| Quick ratio | 0.9x | 0.9x | 0.9x | 1.0x | 0.9x |
| Total assets | $680M | $608M | $564M | $504M | $404M |
| Total liabilities | $476M | $387M | $324M | $274M | $278M |
| Shareholders' equity | $204M | $222M | $240M | $230M | $127M |
| Net debt (− = net cash) | −$40.8M | −$53.6M | −$37.9M | −$21.1M | −$28.3M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ |
| Return on assets rose | — | ✕ | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | — | — | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ |
| Current ratio rose | — | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ |
| Share count didn't rise | — | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ |
| Gross margin rose | — | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Revenue rose relative to assets | — | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ |
| F-score | — / 3 | 5 / 8 | 5 / 8 | 2 / 8 | 7 / 9 | 7 / 9 | 7 / 9 | 5 / 9 | 4 / 9 | 4 / 9 |
| Accruals ratio | −8.0% | −6.6% | −6.6% | −11.7% | −5.9% | −12.4% | −2.7% | −3.2% | −0.4% | −30.9% |
| Altman Z'' | 3.54 | 3.22 | 3.25 | 0.17 | 0.37 | 1.15 | 1.53 | 1.61 | 1.97 | −1.42 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $326M | $338M | $358M | $462M | $449M | $494M | $538M | $481M | $432M | $397M |
| Net interest income | — | — | — | — | — | −$4.2M | −$2.5M | −$3.1M | −$3.0M | −$2.7M |
| Gross profit | $214M | $219M | $229M | $279M | $287M | $312M | $326M | $283M | $250M | $226M |
| Operating income | $30.8M | $27.5M | $22.4M | $1.1M | −$16.2M | $38.6M | $32.7M | $6.8M | $0.7M | −$113M |
| Interest expense | — | — | — | $8.1M | $5.3M | $4.2M | $2.5M | — | — | — |
| Pretax income | $30.7M | $27.4M | $23.5M | −$9.6M | $12.9M | $33.2M | $30.7M | $6.3M | $2.6M | −$119M |
| Income tax | $13.1M | $12.2M | $8.1M | −$0.0M | $2.9M | $8.3M | $8.9M | $3.2M | $8.4M | −$0.0M |
| Net income | $17.7M | $15.1M | $15.4M | −$9.6M | $10.0M | $24.8M | $21.8M | $3.1M | −$5.7M | −$119M |
| Diluted EPS | $0.97 | $0.83 | $0.84 | $0.52 | $0.53 | $1.28 | $1.14 | $0.16 | −$0.30 | −$6.28 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $44.5M | $37.5M | $38.4M | $48.4M | $47.8M | $107M | $39.4M | $21.7M | −$3.9M | $21.1M |
| Capital expenditure | $4.1M | $7.9M | $5.0M | $11.9M | $8.9M | $10.7M | $5.7M | $5.5M | $3.4M | $3.0M |
| Free cash flow | $40.3M | $29.6M | $33.4M | $36.5M | $38.8M | $96.3M | $33.8M | $16.2M | −$7.3M | $18.1M |
| Depreciation and amortization | $7.8M | $6.6M | $8.0M | $8.6M | $9.9M | $9.4M | $9.3M | $8.5M | $7.6M | $6.0M |
| Stock-based compensation | $8.0M | $8.5M | $8.3M | $11.7M | $10.9M | $10.1M | $14.5M | $15.5M | $14.3M | $12.3M |
| Acquisitions | — | — | $9.3M | $238M | $0.0M | $0.0M | — | — | — | — |
| Share buybacks | $1.8M | $40.0M | $9.9M | $0.0M | $0.0M | $20.1M | $15.1M | $4.1M | $15.9M | $2.5M |
| Dividends paid | $13.0M | $13.6M | $14.5M | — | — | — | — | — | — | — |
| Dividends and buybacks | $14.8M | $53.6M | $24.4M | $0.0M | $0.0M | $20.1M | $15.1M | $4.1M | $15.9M | $2.5M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $138M | $134M | $140M | $67.9M | $90.3M | $116M | $104M | $72.9M | $56.1M | $63.3M |
| Total debt | — | — | — | $131M | $108M | $75.0M | $50.0M | $35.0M | $35.0M | $35.0M |
| Current assets | $223M | $237M | $236M | $192M | $217M | $269M | $235M | $216M | $201M | $213M |
| Current liabilities | $177M | $195M | $190M | $269M | $270M | $312M | $269M | $240M | $204M | $240M |
| Property and equipment, net | $23.9M | $25.2M | $22.0M | $29.9M | $27.0M | $28.2M | $23.2M | $19.4M | $11.7M | $11.2M |
| Goodwill | $73.2M | $76.2M | $85.2M | $244M | $247M | $245M | $242M | $244M | $228M | $120M |
| Intangible assets | $1.5M | $0.7M | $5.0M | $97.4M | $78.0M | $62.7M | $49.5M | $37.6M | $27.5M | $18.7M |
| Total assets | $336M | $345M | $354M | $639M | $644M | $680M | $608M | $564M | $504M | $404M |
| Total liabilities | $186M | $204M | $202M | $481M | $458M | $476M | $387M | $324M | $274M | $278M |
| Preferred stock | — | — | — | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $150M | $141M | $152M | $158M | $186M | $204M | $222M | $240M | $230M | $127M |
| Margins | ||||||||||
| Gross margin | 65.6% | 64.8% | 64.1% | 60.5% | 63.9% | 63.1% | 60.5% | 58.8% | 57.8% | 57.0% |
| Operating margin | 9.4% | 8.2% | 6.3% | 0.2% | −3.6% | 7.8% | 6.1% | 1.4% | 0.2% | −28.5% |
| EBITDA margin | 11.8% | 10.1% | 8.5% | 2.1% | −1.4% | 9.7% | 7.8% | 3.2% | 1.9% | −27.0% |
| Net margin | 5.4% | 4.5% | 4.3% | −2.1% | 2.2% | 5.0% | 4.1% | 0.6% | −1.3% | −30.1% |
| FCF margin | 12.4% | 8.8% | 9.3% | 7.9% | 8.7% | 19.5% | 6.3% | 3.4% | −1.7% | 4.6% |
| Net interest share of revenue | — | — | — | — | — | −0.9% | −0.5% | −0.6% | −0.7% | −0.7% |
| Returns | ||||||||||
| Return on capital | — | — | — | 0.4% | −6.1% | 17.7% | 13.8% | 2.2% | 0.2% | −91.1% |
| Return on capital employed | 19.4% | 18.3% | 13.7% | 0.3% | −4.3% | 10.5% | 9.6% | 2.1% | 0.2% | −69.0% |
| Return on equity | 11.8% | 10.4% | 10.5% | −6.2% | 5.8% | 12.8% | 10.2% | 1.3% | −2.4% | −67.0% |
| Return on assets | 5.3% | 4.4% | 4.4% | −1.9% | 1.6% | 3.8% | 3.4% | 0.5% | −1.1% | −26.3% |
| Return on tangible equity | 23.4% | 23.6% | 25.0% | — | — | — | — | — | — | — |
| Growth | ||||||||||
| Revenue growth | — | 3.6% | 5.9% | 29.1% | −2.8% | 10.1% | 8.8% | −10.6% | −10.0% | −8.2% |
| Net income growth | — | −14.2% | 1.6% | −162.2% | — | 148.7% | −12.2% | −86.0% | −288.4% | — |
| EPS growth | — | −14.4% | 1.2% | −38.1% | 1.9% | 141.5% | −10.9% | −86.0% | −287.5% | — |
| FCF growth | — | −26.5% | 12.6% | 9.4% | 6.4% | 147.9% | −64.9% | −52.1% | −144.9% | — |
| Share count change | — | −0.2% | 0.8% | 0.6% | 2.4% | 2.2% | −1.0% | 0.4% | −0.9% | −0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | — | — | — | 6.5x | — | −0.8x | −1.3x | −2.5x | −2.5x | — |
| Debt / equity | — | — | — | 0.8x | 0.6x | 0.4x | 0.2x | 0.1x | 0.2x | 0.3x |
| Interest coverage | — | — | — | 0.1x | −3.0x | 9.2x | 13.3x | — | — | — |
| Current ratio | 1.3x | 1.2x | 1.2x | 0.7x | 0.8x | 0.9x | 0.9x | 0.9x | 1.0x | 0.9x |
| Quick ratio | 1.3x | 1.2x | 1.2x | 0.7x | 0.8x | 0.9x | 0.9x | 0.9x | 1.0x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.3% | 2.3% | 1.4% | 2.6% | 2.0% | 2.2% | 1.1% | 1.1% | 0.8% | 0.8% |
| Stock comp / revenue | 2.4% | 2.5% | 2.3% | 2.5% | 2.4% | 2.0% | 2.7% | 3.2% | 3.3% | 3.1% |
| Payouts / FCF | 36.6% | 180.9% | 73.3% | 0.0% | 0.0% | 20.8% | 44.8% | 25.2% | — | 14.0% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 5.0 | 5.0 | 2.0 | 7.0 | 7.0 | 7.0 | 5.0 | 4.0 | 4.0 |
| Altman Z'' | 3.5 | 3.2 | 3.2 | 0.2 | 0.4 | 1.2 | 1.5 | 1.6 | 2.0 | −1.4 |
| Accruals ratio | −8.0% | −6.6% | −6.6% | −11.7% | −5.9% | −12.4% | −2.7% | −3.2% | −0.4% | −30.9% |
Source: SEC EDGAR XBRL filings (CIK 0001023313). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
